4-chloro-3-methyl-4-(4-(phenylethynyl)phenyl)isochroman-1-one

ID: ALA4513798

PubChem CID: 102233893

Max Phase: Preclinical

Molecular Formula: C24H17ClO2

Molecular Weight: 372.85

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  CC1OC(=O)c2ccccc2C1(Cl)c1ccc(C#Cc2ccccc2)cc1

Standard InChI:  InChI=1S/C24H17ClO2/c1-17-24(25,22-10-6-5-9-21(22)23(26)27-17)20-15-13-19(14-16-20)12-11-18-7-3-2-4-8-18/h2-10,13-17H,1H3

Standard InChI Key:  RVOYQALCIFEEFN-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 27 30  0  0  0  0  0  0  0  0999 V2000
   17.4444  -20.5618    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.4432  -21.3814    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.1513  -21.7903    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.1495  -20.1530    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.8581  -20.5582    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.8570  -21.3789    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.5631  -21.7879    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.2750  -21.3809    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   20.2762  -20.5602    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.5655  -20.1466    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.5609  -22.6051    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   19.5660  -19.3336    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.2753  -18.9256    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.2757  -18.1092    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.5674  -17.6997    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.8574  -18.1127    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.8605  -18.9278    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.2688  -19.7323    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   20.9849  -20.1533    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.5640  -16.8862    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.5629  -16.0690    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.5618  -15.2518    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.2692  -14.8439    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.2685  -14.0275    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.5597  -13.6190    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.8502  -14.0329    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.8544  -14.8480    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  6  2  0
  5  4  2  0
  4  1  1  0
  5  6  1  0
  5 10  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
  7 11  2  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 12  1  0
 10 12  1  0
 10 18  1  0
  9 19  1  0
 20 21  3  0
 15 20  1  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 27 22  1  0
M  END

Associated Targets(Human)

TZM (838 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Human immunodeficiency virus 1 (70413 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 372.85Molecular Weight (Monoisotopic): 372.0917AlogP: 5.13#Rotatable Bonds: 1
Polar Surface Area: 26.30Molecular Species: HBA: 2HBD:
#RO5 Violations: 1HBA (Lipinski): 2HBD (Lipinski): #RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: CX LogP: 6.30CX LogD: 6.30
Aromatic Rings: 3Heavy Atoms: 27QED Weighted: 0.34Np Likeness Score: 0.09

References

1. Huang YM, Alharbi NS, Sun B, Shantharam CS, Rakesh KP, Qin HL..  (2019)  Synthetic routes and structure-activity relationships (SAR) of anti-HIV agents: A key review.,  181  [PMID:31401538] [10.1016/j.ejmech.2019.111566]

Source